The trial tested the drugs in patients with Waldenstrom’s Macroglobulinemia, a type of non-Hodgkin lymphoma.
BeiGene drug fails main goal in late-stage study against AbbVie-J&J rival Imbruvica
More from Industry NewsMore posts in Industry News »
- Serum Institute could export 20-30 million vaccine doses a month to COVAX: Adar Poonawalla
- Pfizer booster shot 95.6 pc effective against Covid-19
- Novartis extends deal to make Pfizer/BioNTech vaccines
- WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Health Minister Mandaviya
- AstraZeneca launches Clinical Data and Insights division in India